Condition
Diabetic Foot Wounds
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 4 (3)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07206862Not ApplicableNot Yet Recruiting
CHEMfoot: DEBRICHEM® in Chronic Diabetic Foot Wounds
NCT02111291Phase 4Completed
Santyl Applications to Diabetic Foot Ulcers
NCT01408277Phase 4Completed
Using Santyl on Diabetic Foot Ulcers
NCT01197898Phase 4Completed
Wound Edge Changes Following Treatment With Santyl
Showing all 4 trials